Skip to main content

Table 2 Multivariate logistic regression of ePWV for LVH prevalence

From: Value of estimated pulse wave velocity to identify left ventricular hypertrophy prevalence: insights from a general population

Variables

Odds ratio (95% CI)

Crude

p Value

Model 1

p Value

Model 2

p Value

ePWV (Per 1 SD increase)

2.700 (2.541, 2.868)

 < 0.001

3.550 (3.228, 3.904)

 < 0.001

2.993 (2.470, 3.628)

 < 0.001

Quartiles of ePWV

Quartile 1

Reference

 

Reference

 

Reference

 

Quartile 2

2.346 (1.825, 3.016)

 < 0.001

2.541 (1.967, 3.284)

 < 0.001

1.524 (1.152, 2.018)

0.003

Quartile 3

5.874 (4.667, 7.393)

 < 0.001

6.703 (5.216, 8.614)

 < 0.001

2.700 (1.977, 3.686)

 < 0.001

Quartile 4

14.222 (11.392, 17.755)

 < 0.001

17.291 (13.150, 22.736)

 < 0.001

4.520 (3.051, 6.698)

 < 0.001

P for trend

 

 < 0.001

 

 < 0.001

 

 < 0.001

  1. Crude: no adjustment; Model 1: adjusted for sex, age, income, education, and physical activity level, current smoking and drinking status; Model 2: further adjusted for BMI, WC, Scr, TC, HDL-c, FPG, MBP, anti-hypertensive therapy, anti-diabetic therapy, lipid-lowering therapy, and CVD history
  2. ePWV estimated pulse wave velocity, LVH left ventricular hypertrophy, CI confidence interval, BMI body mass index, WC waist circumference, FPG fasting plasma glucose, MBP mean blood pressure, Scr serum creatinine, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, CVD cardiovascular disease, SD standard deviation